SignatureFD’s Standard BioTools LAB Stock Holding History

SignatureFD’s Portfolio LAB Stock Details LAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-317	Closed	-$406	–	3545
2025 Q4	$406	Hold	317	–	–	﹤0.01%	3253
2025 Q3	$412	Hold	317	–	–	﹤0.01%	3221
2025 Q2	$380	Sell	317 -4,853	-94%	-$5.38K	﹤0.01%	3143
2025 Q1	$5.58K	Buy	+5,170	New	+$7.26K	﹤0.01%	2563
2022 Q1	–	Sell	-13,989	Closed	-$55K	–	3240
2021 Q4	$55K	Sell	13,989 -719	-5%	-$3.37K	﹤0.01%	1287
2021 Q3	$97K	Hold	14,708	–	–	﹤0.01%	988
2021 Q2	$91K	Buy	14,708 +217	+1%	+$1.16K	﹤0.01%	991
2021 Q1	$65K	Buy	+14,491	New	+$79.6K	﹤0.01%	1050

Other funds holding LAB

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

MCO

MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HBWM

Hollow Brook Wealth Management Katonah, New York $392M AUM 36.68% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

SignatureFD's LAB Position: Q1 2026 in Review

SignatureFD sold out of Standard BioTools (LAB) in Q1 2026, closing a stake of 317 shares — an estimated $406 sold.

SignatureFD first reported a position in LAB in Q1 2021 and held it in 8 quarters. The position peaked at $97K in Q3 2021. 155 funds tracked by Wall St. Rank hold LAB as of Q1 2026.

SignatureFD reported no remaining Standard BioTools position as of Q1 2026 after selling out during the quarter.
SignatureFD sold 317 Standard BioTools shares in Q1 2026, an estimated $406.
SignatureFD first reported a position in Standard BioTools in Q1 2021 and held it in 8 quarters.
SignatureFD's Standard BioTools position peaked at $97K in Q3 2021.
155 funds tracked by Wall St. Rank held Standard BioTools as of Q1 2026.

Based on SignatureFD's 13F filing for Q1 2026, filed 7 Apr 2026.